Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
05/01/2003 | WO2002044694A3 Permeability measurement |
05/01/2003 | WO2002039109A3 Method for the detection of human hematopoietic short term repopulating cells |
05/01/2003 | WO2002038600A3 C. elegans genes involved in viability and/or reproduction and uses thereof |
05/01/2003 | WO2002035205A8 Process for detecting or quantifying a biological reaction using superparamagnetic label |
05/01/2003 | WO2002031477A3 Fiber optic apparatus and use thereof in combinatorial material science |
05/01/2003 | WO2002027023A3 Genetic determinants for dermal inflammation and immunity |
05/01/2003 | WO2002022851A3 Novel tumor-associated marker |
05/01/2003 | WO2002005146A3 Method for disigning protein libraries with altered immunogenicity |
05/01/2003 | WO2002004671A3 Improved binding interactions in dipstick assays |
05/01/2003 | WO2002004527A3 Encoding methods using up-converting phosphors for high-throughput screening of catalysts |
05/01/2003 | WO2001079291A3 Secreted proteins |
05/01/2003 | WO2001066572A3 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
05/01/2003 | WO2001024681A3 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same |
05/01/2003 | WO2000071564A3 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer |
05/01/2003 | US20030084471 Methods and compositions for RNA interference |
05/01/2003 | US20030084023 Graphical viewer for biomolecular sequence data |
05/01/2003 | US20030083980 Greenhouse effect gas emission index monitoring and converting system |
05/01/2003 | US20030083828 Sheet parameter measurement |
05/01/2003 | US20030083822 Systems and methods for monitoring behavior informatics |
05/01/2003 | US20030083821 Fast secondary structure discovery method for protein folding |
05/01/2003 | US20030083686 Tissue penetration device |
05/01/2003 | US20030083685 Sampling module device and method |
05/01/2003 | US20030083558 Method of examining and diagnosing skin health |
05/01/2003 | US20030083487 Progestogen receptor polypeptides, transgenic cells in which genes encoding said polypeptides are introduced and method for detecting disruptors for progestogens by using said transgenic cells |
05/01/2003 | US20030083481 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of prostate cancer |
05/01/2003 | US20030083479 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030083470 Polypeptide for use in controlling gene transcription and treating cancer |
05/01/2003 | US20030083469 Allosteric control of nuclear hormone receptors |
05/01/2003 | US20030083468 Polypeptide for use in the treatment of inflammation and liver disorders |
05/01/2003 | US20030083466 cDNA clone MY1 that encodes a novel human 7-transmembrane receptor |
05/01/2003 | US20030083462 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030083461 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030083373 Synthetic molecules that specifically react with target sequences |
05/01/2003 | US20030083339 Using antagonists of the Angiotensin II type 2 receptor (AT2 receptor) for example candesartan cilexetil; combination treatment with an ACE inhibitor (angiotensin converting enzyme=ACE); drug screening assays |
05/01/2003 | US20030083294 Enhancing or inhibiting the biological activity of nucleic acid ligands by administrating a modulator, to change the binding of the nucleic acid ligand for its target or degrading or cleaving |
05/01/2003 | US20030083277 Use of insulin degrading enzyme (IDE) for the treatment of alzheimer's disease in patients |
05/01/2003 | US20030083253 Polynucleotide encoding autoantigens associated with endometriosis |
05/01/2003 | US20030083248 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030083246 Methods for treating rheumatic diseases using a soluble CTLA4 molecule |
05/01/2003 | US20030083229 Isolating T cells from mammal, incubating cells with protein expression product of activated oncogene or cancer-related gene associated with malignancy, detecting presence or absence of proliferation of T cells, determining malignancy |
05/01/2003 | US20030082832 Determination of analyte concentration using two labelling markers |
05/01/2003 | US20030082831 Apparatus for use in the synthesis of preferential biopolymers |
05/01/2003 | US20030082830 Compound for use as diagnostic and therapeutic tools in medicine and science |
05/01/2003 | US20030082829 Novel 8.4 kDa immunophilin |
05/01/2003 | US20030082828 Analyzing human blood coaggulation factor XIII (FXIII) levels; immunoassay |
05/01/2003 | US20030082827 Determining conformational state protein; obtain protein, incubate with labeled probe, detect signal from bound labeled probe, signal from probe indicates conformational adjustment |
05/01/2003 | US20030082822 Method of determining measurement bias in an emissions monitoring system |
05/01/2003 | US20030082821 Method and system for monitoring combustion source emissions |
05/01/2003 | US20030082819 Classification of dimethylarginine structure; obtain sample, expose to spectrum analysis, detect presence of dimethylarginine |
05/01/2003 | US20030082817 Detemination of oxygen demand in food processing; prepare glucose solution, mix with mercuric sulfate, potassium dichromate and sulfuric acid, prepare diagram of oxygen demand |
05/01/2003 | US20030082816 Inert gas fusion analyzer |
05/01/2003 | US20030082802 Preparing culture of nervous system tissues; prepare nutrient broth containing agonist, inoculate with nervous system stem cells, propagate and recover cells |
05/01/2003 | US20030082800 Expression vector for use in the generation of single stranded nucleotide sequences |
05/01/2003 | US20030082797 Device and method for taking biological sample |
05/01/2003 | US20030082766 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030082765 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030082764 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030082763 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030082762 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
05/01/2003 | US20030082761 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030082760 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
05/01/2003 | US20030082759 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030082758 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors |
05/01/2003 | US20030082748 Nucleotide sequences coding polypeptides for use in the treatment of leukemia, tumors, psoriasis, chronic infections, autoimmune and fibrotic disorders; wound healing agents |
05/01/2003 | US20030082740 Antitumor agent for use in the treatment of cancer |
05/01/2003 | US20030082739 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
05/01/2003 | US20030082727 Modulatory proteins of human CNS receptors |
05/01/2003 | US20030082725 DNA encoding a novel human inhibitor-of-apoptosis protein |
05/01/2003 | US20030082719 Generation of preferential lymphocyte receptor; generate nucleotide sequence coding receptor protein, transform cell, express nucleotide sequences, recover receptor protein, evaluate binding activity |
05/01/2003 | US20030082713 Detection of preferential nucleotide sequences in sample; obtain nucleotide sequences sample, incubate with labeled oligonucleotide, denature, monitor chemiluminescence emission and compare to control |
05/01/2003 | US20030082712 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030082711 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030082710 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030082709 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030082708 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
05/01/2003 | US20030082707 Membrane protein for use as tool in human therapeutics and diagnostics |
05/01/2003 | US20030082706 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
05/01/2003 | US20030082705 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
05/01/2003 | US20030082704 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030082703 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030082702 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
05/01/2003 | US20030082701 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
05/01/2003 | US20030082700 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030082699 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030082698 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
05/01/2003 | US20030082697 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
05/01/2003 | US20030082696 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
05/01/2003 | US20030082695 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
05/01/2003 | US20030082694 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030082693 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
05/01/2003 | US20030082692 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
05/01/2003 | US20030082691 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030082690 Nucleotide sequences coding polypeptides for use in the diagnosis, prevention and treatment cell proliferative and tumor disorders |
05/01/2003 | US20030082689 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030082687 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030082686 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/01/2003 | US20030082684 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
05/01/2003 | US20030082683 Nucleotide sequences coding transport protein for use in the treatment of cancer, heart and viral diseases |
05/01/2003 | US20030082674 Genetically engineered receptor protein for use in the treatment of respiratory system disorders |
05/01/2003 | US20030082672 Dna encoding galanin galr2 receptors and uses thereof |